This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Rule
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
30
as of
10/11/2026 at 8:15 pm EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Social Security Administration (SSA).
ACTION:
Final rule.
SUMMARY:
We adjudicate claims at the third step of our sequential evaluation process for evaluating disability using the Listing of Impairments (the Listings) under the Social Security and Supplemental Security Income (SSI) programs. This final rule extends until July 2, 2003, the date on which several body system listings will no longer be effective. We have made no revisions to the medical criteria in these listings; they remain the same as they now appear in the Code of Federal Regulations. This extension will ensure that we continue to have medical evaluation criteria in the listings to adjudicate claims for disability based on impairments in these body systems at step three of our sequential evaluation process.
EFFECTIVE DATE:
This final regulation is effective June 28, 2001.
FOR FURTHER INFORMATION CONTACT:
Deborah Barnes, Social Insurance Specialist, Office of Disability, Social Security Administration, 3-A-8 Operations Building, 6401 Security Boulevard, Baltimore, MD 21235-6401, (410) 966-1203 or TTY (410) 966-5609. For information on eligibility or filing for benefits, call our national toll-free number, 1-800-772-1213 or TTY 1-800-325-0778, or visit our Internet web site, Social Security Online, at
www.ssa.gov.
SUPPLEMENTARY INFORMATION:
We use the Listings in appendix 1 to subpart P of part 404 at the third step of the sequential evaluation process to evaluate claims filed by adults and children for benefits based on disability under the Social Security and SSI programs. The Listings are divided into parts A and B. We use the criteria in part A to evaluate the impairments of adults. We first use the criteria in part B to evaluate impairments of children. If the criteria in part B do not apply, then we will apply the medical criteria in part A.
In this final rule, we are extending until July 2, 2003, the dates on which several body system listings will no longer be effective to allow sufficient
( printed page 34362)
time for us to revise them. These body systems are:
Growth Impairment (100.00)
Musculoskeletal System (1.00 and 101.00)
Special Senses and Speech (2.00 and 102.00)
Cardiovascular System (4.00 and 104.00)
Digestive System (5.00 and 105.00)
Genito-Urinary System (6.00 and 106.00)
Hemic and Lymphatic System (7.00 and 107.00)
Skin (8.00)
Endocrine System (9.00 and 109.00)
Multiple Body Systems (110.00)
Neurological (11.00 and 111.00)
Mental Disorders (12.00 and 112.00)
Neoplastic Diseases, Malignant (13.00 and 113.00)
Immune System (14.00 and 114.00)
As a result of medical advances in disability evaluation and treatment, and program experience, we should periodically review and update the Listings. We are extending these dates because we will not complete revised listings criteria for these body systems by the current expiration dates. Currently, we are in the process of revising these body system listings and intend to publish proposed and final rules for each body system listings in a timely manner, with all revisions complete prior to the new extension date.
We last extended the dates on which these body system listings would no longer be effective to July 2, 2001, in final rules published as follows:
June 3, 1999 (64 FR 29786): Growth Impairment; Musculoskeletal System; Special Senses and Speech; Hemic and Lymphatic System; Skin; Endocrine System; Multiple Body Systems; Neurological; Mental Disorders; Neoplastic Diseases, Malignant; and Immune System.
December 3, 1999 (64 FR 67719): Cardiovascular System, Digestive System, and Genito-Urinary System.
Until we publish revised language for each body system listings, the current listings language is valid for our program purposes.
Regulatory Procedures
Justification for Final Rule
Pursuant to section 702(a)(5) of the Social Security Act, 42 U.S.C. 902(a)(5), we follow the Administrative Procedure Act (APA) rulemaking procedures specified in 5 U.S.C. 553 in the development of our regulations. The APA provides exceptions to its notice and public comment procedures when an agency finds there is good cause for dispensing with such procedures on the basis that they are impracticable, unnecessary, or contrary to the public interest. We have determined that, under 5 U.S.C. 553(b)(B), good cause exists for dispensing with the notice and public comment procedures for this rule. Good cause exists because this final rule only extends the date on which these body system listings will no longer be effective. It makes no substantive changes to those listings. The current regulations expressly provide that listings may be extended, as well as revised and promulgated again. Therefore, we have determined that opportunity for prior comment is unnecessary, and we are issuing this regulation as a final rule.
In addition, we find good cause for dispensing with the 30-day delay in the effective date of a substantive rule provided by 5 U.S.C. 553(d). As explained above, we are not making any substantive changes in these body system listings. However, without an extension of the expiration dates for these listings, we will lack regulatory criteria for assessing impairments in these body systems at the third step of the sequential evaluation process after the current expiration dates of these listings. In order to ensure that we continue to have regulatory criteria for assessing impairments under these listings, we find that it is in the public interest to make this rule effective on publication.
The Office of Management and Budget (OMB) has reviewed this final rule in accordance with Executive Order (E.O.) 12866. We have also determined that this final rule meets the plain language requirement of E.O. 12866.
Regulatory Flexibility Act
We certify that this final rule will not have a significant economic impact on a substantial number of small entities. Therefore, a regulatory flexibility analysis as provided in the Regulatory Flexibility Act, as amended, is not required.
Paperwork Reduction Act
This final rule imposes no reporting/recordkeeping requirements necessitating clearance by OMB.
(Catalog of Federal Domestic Assistance Program Nos. 96.001, Social Security-Disability Insurance; 96.002, Social Security-Retirement Insurance; 96.004, Social Security-Survivors Insurance; 96.006, Supplemental Security Income)
PART 404—FEDERAL OLD-AGE, SURVIVORS AND DISABILITY INSURANCE (1950- )
Subpart P—[Amended]
1. The authority citation for subpart P of part 404 continues to read as follows:
Authority:Secs. 202, 205(a), (b), and (d)-(h), 216(i), 221(a) and (i), 222(c), 223, 225, and 702(a)(5) of the Social Security Act (42 U.S.C. 402, 405(a), (b), and (d)-(h), 416(i), 421(a) and (i), 422(c), 423, 425, and 902(a)(5)); sec. 211(b), Pub. L. 104-193, 110 Stat. 2105, 2189.
2. Appendix 1 to subpart P of part 404 is amended by revising items 1, 2, 3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, and 15 of the introductory text before Part A to read as follows:
Appendix 1 to Subpart P of Part 404—Listing of Impairments
* * * * *
1. Growth Impairment (100.00): July 2, 2003.
2. Musculoskeletal System (1.00 and 101.00): July 2, 2003.
3. Special Senses and Speech (2.00 and 102.00): July 2, 2003.
* * * * *
5. Cardiovascular System (4.00 and 104.00): July 2, 2003.
6. Digestive System (5.00 and 105.00): July 2, 2003.
7. Genito-Urinary System (6.00 and 106.00): July 2, 2003.
8. Hemic and Lymphatic System (7.00 and 107.00): July 2, 2003.
9. Skin (8.00): July 2, 2003.
10. Endocrine System (9.00 and 109.00): July 2, 2003.
11. Multiple Body Systems (10.00): June 19, 2008, and (110.00): July 2, 2003.
12. Neurological (11.00 and 111.00): July 2, 2003.
13. Mental Disorders (12.00 and 112.00): July 2, 2003.
14. Neoplastic Diseases, Malignant (13.00 and 113.00): July 2, 2003.
15. Immune System (14.00 and 114.00): July 2, 2003.